Press Releases

10 Jan '23
CHICAGO --(BUSINESS WIRE)--Jan. 10, 2023-- Veradigm Inc. (NASDAQ: MDRX) reports today strong fourth quarter new business results across all markets including the payer, life science, and provider markets. The Veradigm Payer business added 6 net-new regional and national payer clients in Q4,
09 Jan '23
This collaboration fuels the expansion of a leading source of real-world clinical behavioral health data CHICAGO --(BUSINESS WIRE)--Jan. 9, 2023-- Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc. , announced today an investment in Holmusk, a global behavioral health
06 Jan '23
CHICAGO --(BUSINESS WIRE)--Jan. 6, 2023-- Veradigm Inc. (Nasdaq:MDRX), formerly Allscripts Healthcare Solutions Inc. , announced today that Rick Poulton , Veradigm Chief Executive Officer, will present at the 2023 J.P. Morgan Healthcare conference on Wednesday, January 11, 2023 at 3:45 PST .
03 Jan '23
CHICAGO --(BUSINESS WIRE)--Jan. 3, 2023-- Allscripts Healthcare Solutions, Inc. announced today that, effective January 1, 2023 , it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand during 2022, and Allscripts will now
09 Nov '22
Supporting healthcare practices to successfully meet federal reporting requirements CHICAGO --(BUSINESS WIRE)--Nov. 9, 2022-- Veradigm, a business unit of Allscripts (NASDAQ: MDRX), announced today that Veradigm EHR (formerly known as Professional EHR) has achieved 2015 ONC Health IT Update
03 Nov '22
Third quarter consolidated revenue of $152 million Third quarter consolidated operating profit up over 30% year-over-year Generated $42 million of cash flow from continuing operations in the quarter CHICAGO --(BUSINESS WIRE)--Nov. 3, 2022-- Allscripts Healthcare Solutions, Inc.

Contact Investor Relations

Jenny Gelinas
Vice President, Investor Relations